Urinary tract infection (uti)

Mohammand Kabbani*, Mario Kramer

*Corresponding author for this work


Urinary tract infections (UTIs) are one of the most common infections in modern medicine, ranking second after respiratory tract infections, causing more than seven million physicians’ visits and 100,000 hospitalizations per year in the USA [ 1, 2 ]. UTIs are responsible for nearly 15 % of all community prescription antibiotics and are causes for more than one billion dollar costs per year to manage them [ 1, 3 ]. Women are in general more likely to be affected with UTIs. Almost half of all women will experience at least one UTI during their lifetime [ 3 ]. High prevalence of UTIs in conjunction with inappropriate and excessive antimicrobial treatment are risk factors of increasing antibiotic resistance. Since many clinical studies regarding treatment of UTIs have investigated women in large healthcare facilities in the USA, physicians should evaluate whether reviews and guidelines for UTI treatment are suitable to their local patients population. On the other side, inconsequent therapy of UTIs may result in potentially lethal urosepsis, renal abscess formation, and chronic pyelonephritis.

Original languageEnglish
Title of host publicationUrology at a Glance
Number of pages4
PublisherSpringer Berlin Heidelberg
Publication date01.01.2014
ISBN (Print)9783642548581
ISBN (Electronic)9783642548598
Publication statusPublished - 01.01.2014

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)


Dive into the research topics of 'Urinary tract infection (uti)'. Together they form a unique fingerprint.

Cite this